PharMerica and its subsidiary Amerita’s Specialty Infusion Services (Amerita) are already facing class action lawsuits after patients received a September 5, 2023, data breach notification letter. When the businesses detected suspicious activity on both the PharMerica and Amerita networks, a forensic investigation determined that a threat actor had gained access to the systems sometime in

PharMerica settled a Telephone Consumer Protection Act (TCPA) class action initiated by a group of nursing homes over allegations that the pharmacy inundated the nursing homes with unsolicited fax advertisements in violation of the TCPA. The class action was filed back in October 2013 after PharMerica sent out over 100 fax-blasts to advertise the “PharMerica